{"metadata": {"organization_names": ["lippenberger, thompson"], "person_names_verified": ["eugene khoo kay jin", "chu swee yeok", "carl strachan", "michael d. west", "richard s. soroko"], "organization_names_verified": ["wells fargo bank national association", "es cell australia", "biotime inc.", "soroko & gilbert", "wells fargo bank", "es cell international pte ltd", "biomedical sciences investment fund pte ltd", "biotime, inc.", "pharmbio growth fund pte ltd"], "vars": {}, "entities_rejected": [], "person_names": [], "agreement_id": "3f50ff8338c852f33d7d601567588bfb47a2baac0ebf97e554266cf61342ece4", "topics": [], "terms": ["\"**BMSIF**\"", "\"**Closing Date**\"", "\"**Corporate**", "\"**Corporate** **Event**\"", "\"**ESCA**\"", "\"**Escrow Claim**\"", "\"**Escrow**", "\"**Escrow** **Agent**\"", "\"**Escrow** **Agreement**\"", "\"**Escrow** **Shares**\"", "\"**PGH**\"", "\"**Principal**", "\"**Purchase Price**\"", "\"**Purchase**", "\"**Purchase** **Agreement**\", attached to this Agreement as Exhibit A) for Purchaser's acquisition of ordinary shares, preference shares, and promissory notes of ES Cell International Pte Ltd, a Singapore private limited company, whose registered office is at 60 Biopolis Street #01-03 Genome Singapore 138672 (the \"**Purchase**\"", "\"**Purchase**\"", "\"**Purchaser**\"", "\"**Setoff**\"", "\"**Transfer**", "\"**Transfer** **Agent**\"", "**Agent**\"", "**Agreement**\"", "**Amendment**", "**BioTime, Inc.**", "**Biomedical Sciences Investment Fund Pte Ltd**", "**Certificate as to Authorized Signatures**", "**Closing Date**", "**Compensation**", "**Contact Addresses and Numbers for Principal Vendors**", "**Corporate, Municipal and Escrow Services**", "**Counterparts**", "**DUTIES OF THE ESCROW AGENT**", "**ES Cell Australia Limited**", "**ESCROW AGREEMENT**", "**ESCROW DEPOSIT**", "**Entire Agreement**", "**Escheat**", "**Escrow Agent Fees**", "**Escrow Shares**", "**Event**\"", "**Exhibit A**", "**Exhibit B**", "**Force Majeure**", "**Further Assurances**", "**Governing Law**", "**Headings**", "**Indemnification**", "**Limitation of Liability**", "**MISCELLANEOUS**", "**Merger or Consolidation**", "**Name and Particulars**", "**No Financial Obligation**", "**Notices**", "**Number of Common Shares of Purchaser Held in Escrow**", "**PROVISIONS CONCERNING THE ESCROW AGENT**", "**Pharmbio Growth Fund Pte Ltd**", "**Purchase Agreement**", "**RECITALS**", "**Receipt of Escrow Shares**", "**Reliance**", "**Resignation**", "**Right Not Duty Undertaken**", "**Schedule 1**", "**Schedule 3.4**", "**Schedule 4.4**", "**Scope of Responsibility**", "**Shares**\"", "**Stock Transfer Power**", "**Successors and Assigns**", "**Total**", "**Vendors**", "**Waivers**", "**Wells Fargo Bank, National Association**", "**[[Address 6: Address]]**", "\u201c**Breaching Principal Vendor**\u201d", "\u201c**Escrow Termination Date**\u201d", "\u201c**Escrow**\u201d", "\u201c**Parties**", "\u201c**Relevant Escrow Shares**\u201d", "\u201c**Resignation Notice**\u201d", "\u201c**Share Certificates**\u201d"]}}